Glimepiride & Metformin Hydrochloride SR Bi-layer Tablets 2mg/1000mg

Glimepiride & Metformin Hydrochloride SR Bi-layer Tablets 2mg/1000mg
Product Name:Glimepiride & Metformin Hydrochloride Sustained Release Tablets
Brand Name:Generic
Strength:1mg+500mg, 2mg+500mg, 3mg+500mg, 3mg+850mg, 1mg+1000mg, 2mg+1000mg, 3mg+1000mg
, Dosage Form:uncoated tablet
Route of Administration:Via Oral Route
Packing:10s, 30s
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Stability Studies, GMP, COPP, CTD DOSSIER
Therapeutic use:Antidiabetic
Indication:Treatment of diabetes mellitus type 2 (in addition to diet, physical exercise and weight loss).
Storage:Store in a cool and dry place, Protected from light.

GENERIC NAME OF THE MEDICINAL PRODUCT:

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (1mg+500mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….1mg
    Metformin Hydrochloride IP………………………. 500mg
    (in sustained release form)
    Excipients q.s.   
  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (2mg+500mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….2mg
    Metformin Hydrochloride IP………………………. 500mg
    (in sustained release form)
    Excipients q.s.   
  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (3mg+500mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….3mg
    Metformin Hydrochloride IP………………………. 500mg
    (in sustained release form)
    Excipients q.s.   
  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (3mg+850mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….3mg
    Metformin Hydrochloride IP………………………. 850mg
    (in sustained release form)
    Excipients q.s.   
  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (1mg+1000mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….1mg
    Metformin Hydrochloride IP………………………. 1000mg
    (in sustained release form)
    Excipients q.s.   
  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (2mg+1000mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….2mg
    Metformin Hydrochloride IP………………………. 1000mg
    (in sustained release form)
    Excipients q.s.   
  • Glimepiride & Metformin Hydrochloride Sustained Release Tablets (3mg+1000mg)
    Each uncoated tablet contains:
    Glimepiride IP ………………….3mg
    Metformin Hydrochloride IP………………………. 1000mg
    (in sustained release form)
    Excipients q.s.   

THERAPEUTIC INDICATIONS:

Treatment of diabetes mellitus type 2 (in addition to diet, physical exercise and weight loss).

CAUTION & SCHEDULE:
CAUTION AND SCHEDULE: 

Keep this and all medication out of reach and sight of children.
SCHEDULE: SCHEDULE ‘H’ DRUG – To be sold by retail on the prescription of a Registered Medical Practitioner only.
Caution: It is dangerous to take this preparation except under medical supervision.

STORAGE & DOSAGE:

Storage: Store in a cool and dry place, Protected from light.
Dosage: As directed by the Physician.

Leave a Reply